Akili to operate as wholly owned subsidiary of Virtual Therapeutics
Akili to operate as a wholly owned subsidiary of Virtual Therapeutics. PureTech Health, a clinical-stage biotherapeutics company, noted today that its Founded Entity, Akili, Inc. (Nasdaq: AKLI), a leading digital therapeutics company, and Virtual Therapeutics, a company focused on improving mental health at scale using engaging, immersive games, announced the signing of a definitive merger agreement to form a diversified, leading digital health company.
Akili's founder is UCSF professor Adam Gazzaley.